Iovance
is a California-based biotechnology company that researches and develops tumor-infiltrating lymphocyte therapies for the treatment of cancer... Read moreIovance
is a California-based biotechnology company that researches and develops tumor-infiltrating lymphocyte therapies for the treatment of cancer... Read more
2007
PublicNASDAQIOVA
News
Apr 23, 2025
Nasdaq
Iovance: Iovance Biotherapeutics Stock Is Crashing. And Here's Why Things Could Get Even Worse This Year.
Apr 23, 2025
Benzinga
Iovance: Iovance Biotherapeutics Announces Participation in Upcoming Scientific Congresses
Apr 22, 2025
Seeking Alpha
Iovance: Iovance Biotherapeutics: Only For The Brave
Apr 21, 2025
Nasdaq
Iovance: Commit To Buy Iovance Biotherapeutics At $2.50, Earn 35.1% Annualized Using Options
Apr 18, 2025
Nasdaq
Iovance: Iovance Biotherapeutics Grants Inducement Stock Options to Fifty New Employees
Mar 23, 2025
Americanbankingnews
Iovance: Research Analysts Offer Predictions for IOVA FY2027 Earnings
Mar 18, 2025
Seeking Alpha
Iovance: Iovance: The Company Makes It Hard To Estimate Revenue Growth
Mar 12, 2025
The Business Journals: Philadelphia
Iovance: Iovance expects to add hundreds of jobs at Navy Yard cell therapy center
Feb 28, 2025
Owler
IOVANCE Biotherapeutics, Inc.: Iovance's employee count changed from 557 in Dec 2023 to 838 in Dec 2024
Feb 28, 2025
Seeking Alpha
Iovance: Iovance Biotherapeutics, Inc. (IOVA) Q4 2024 Earnings Call Transcript
Iovance Competitors
1
2
3
4
5
6
7
8
9
10